Standard InChI: InChI=1S/C30H41N7O4/c1-41-24-12-13-25-26(20-24)34-30(32-17-16-31-27(38)10-6-3-7-11-28(39)36-40)35-29(25)33-23-14-18-37(19-15-23)21-22-8-4-2-5-9-22/h2,4-5,8-9,12-13,20,23,40H,3,6-7,10-11,14-19,21H2,1H3,(H,31,38)(H,36,39)(H2,32,33,34,35)
1.Kargbo RB.. (2018) Histone Deacetylase Inhibitors as Treatment for Targeting Multiple Components in Cancer Therapy., 9 (3):[PMID:29541353][10.1021/acsmedchemlett.8b00068]
2.Rabal O, San José-Enériz E, Agirre X, Sánchez-Arias JA, de Miguel I, Ordoñez R, Garate L, Miranda E, Sáez E, Vilas-Zornoza A, Pineda-Lucena A, Estella A, Zhang F, Wu W, Xu M, Prosper F, Oyarzabal J.. (2021) Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma., 64 (6.0):[PMID:33661013][10.1021/acs.jmedchem.0c02255]